Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
1.
J Vasc Interv Radiol ; 31(9): 1475-1482.e2, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32800663

ABSTRACT

PURPOSE: To evaluate the effects of hepatic artery embolization (HAE) on the expression of programmed cell death 1 ligand 1 (PD-L1) in an orthotopic rat hepatocellular carcinoma (HCC) model. MATERIALS AND METHODS: A rat HCC model was established in Sprague-Dawley rats with the RH7777 cell line. Six animals each were assigned to receive HAE or sham treatment. Liver tissues were harvested 24 h after the procedure. Immunohistochemistry (IHC) was used to compare expression of PD-L1 and hypoxia-inducible factor (HIF)-1α in the intratumoral and peritumoral regions and normal liver tissue. In vitro cell culture study was performed for 24 h under normoxic and hypoxic conditions, and protein expression of PD-L1 and HIF-1α and the effects of HIF-1α inhibitors were assessed. RESULTS: IHC showed that PD-L1- and HIF-1α-positive areas were significantly larger in the HAE group vs the sham group in intratumoral (P = .006 and P < .001, respectively) and peritumoral regions (both P < .001). The expression of PD-L1 positively correlated with HIF-1α expression in the intratumoral region (r2 = 0.551; P < .001). In vitro cell culture study revealed that protein expression of PD-L1 and HIF-1α were significantly higher when cells were incubated under hypoxic vs normoxic conditions (P = .028 and P = .010, respectively). PD-L1 expression was suppressed significantly when the HIF-1α inhibitor rapamycin was added to the culture medium (P = .024). CONCLUSIONS: HAE enhances intratumoral and peritumoral PD-L1 expression in a rat HCC model. The HIF-1α pathway is a possible mechanism underlying increased intratumoral PD-L1 expression after HAE.


Subject(s)
B7-H1 Antigen/metabolism , Carcinoma, Hepatocellular/therapy , Embolization, Therapeutic , Hepatic Artery , Liver Neoplasms, Experimental/therapy , Animals , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/pathology , Male , Rats, Sprague-Dawley , Signal Transduction , Tumor Microenvironment , Up-Regulation
2.
J Transl Med ; 16(1): 51, 2018 03 07.
Article in English | MEDLINE | ID: mdl-29514661

ABSTRACT

BACKGROUND: The cytokine interleukin-18 was originally identified as an interferon-γ-inducing proinflammatory factor; however, there is increasing evidence to suggest that it has non-immunological effects on physiological functions. We previously investigated the potential pathophysiological relationship between interleukin-18 and dyslipidemia, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis, and suggested interleukin-18 as a possible novel treatment for not only these diseases but also for cancer immunotherapy. Before clinical application, the effects of interleukin-18 on the kidney need to be determined. In the current study, we examined the kidney of interleukin-18 knockout (Il18-/-) mice and the effects of interleukin-18 on the kidney following intravenous administration of recombinant interleukin-18. METHODS: Il18-/- male mice were generated on the C57Bl/6 background and littermate C57Bl/6 Il18+/+ male mice were used as controls. To assess kidney damage, serum creatinine and blood urea nitrogen levels were measured and histopathological analysis was performed. For molecular analysis, microarray and quantitative reverse transcription PCR was performed using mice 6 and 12 weeks old. To evaluate the short- and long-term effects of interleukin-18 on the kidney, recombinant interleukin-18 was administered for 2 and 12 weeks, respectively. RESULTS: Compared with Il18+/+ mice, Il18-/- mice developed kidney failure in their youth-6 weeks of age, but the condition was observed to improve as the mice aged, even though dyslipidemia, arteriosclerosis, and higher insulin resistance occurred. Analyses of potential molecular mechanisms involved in the onset of early kidney failure in Il18-/- mice identified a number of associated genes, such as Itgam, Nov, and Ppard. Intravenous administration of recombinant interleukin-18 over both the short and long term showed no effects on the kidney despite significant improvement in metabolic diseases. CONCLUSIONS: Short- and long-term administration of interleukin-18 appeared to have no adverse effects on the kidney in these mice, suggesting that administration may be a safe and novel treatment for metabolic diseases and cancer.


Subject(s)
Gene Expression Regulation/drug effects , Interleukin-18/administration & dosage , Interleukin-18/pharmacology , Kidney/physiology , Animals , Kidney/drug effects , Kidney/pathology , Kidney Function Tests , Male , Mice, Inbred C57BL , Recombinant Proteins/pharmacology , Time Factors
3.
J Transl Med ; 16(1): 314, 2018 11 19.
Article in English | MEDLINE | ID: mdl-30453990

ABSTRACT

BACKGROUND: The cytokine, interleukin-18 (IL-18), was originally identified as an interferon-γ-inducing proinflammatory factor; however, there is increasing evidence suggesting that it has non-immunological effects on physiological functions. We have previously investigated the potential pathophysiological relationship between IL-18 and dyslipidemia, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, which were mediated by lipid energy imbalance. Therefore, herein we focused on brown adipocytes (BAs) and brown adipose tissue (BAT) related to energy consumption as non-shivering thermogenesis. METHODS: Il18-/- male mice were generated on the C57Bl/6 background, and littermate C57Bl/6 Il18+/+ male mice were used as controls. To reveal the direct effect of IL-18, primary cell cultures derived from both mice were established. Moreover, for molecular analysis, microarray, quantitative reverse transcription PCR and western blotting were performed using 6 and 12 weeks old mice. To evaluate the short- and long-term effects of IL-18 on BAT, recombinant IL-18 was administered for 2 and 12 weeks, respectively. RESULTS: Compared with Il18+/+ mice, BAT of Il18-/- mice showed earlier differentiation and lipid accumulation. To examine the direct effect of IL-18 on BAT, BA cell cultures were established. Myogenic factor 5-expressing adipose precursor cells were extracted from Il18+/+ and Il18-/- mice. PR domain containing 16 (PRDM16), a differentiation inducer, was strongly expressed in Il18-/- BAs, and uncoupling protein 1, a thermogenic and differentiation marker, was upregulated, resulting in the promotion of BA differentiation. Moreover, PRDM16-dependent and independent molecules related to BAT function, such as fibroblast growth factor 21, were activated. These findings were confirmed by comparing Il18+/+ and Il18-/- mice at 6 and 12 weeks of age. Additional analyses of the molecular mechanisms influencing the 'Quantity of adipocytes' identified three associated genes, apolipoprotein C3 (Apoc3), insulin-induced gene 1 (Insig1) and vitamin D (1,25-dihydroxyvitamin D3) receptor (Vdr). Intravenous administration of IL-18 not only significantly improved the expression of some of these genes, but it also significantly decreased the adipocytes' size. CONCLUSIONS: This study demonstrated the critical function of IL-18 in differentiation and lipid metabolism in BAs. Furthermore, IL-18 may contribute to novel treatments by improving the energy imbalance.


Subject(s)
Adipose Tissue, Brown/pathology , Adiposity , Cell Differentiation , Dyslipidemias/metabolism , Dyslipidemias/pathology , Interleukin-18/deficiency , Adipogenesis/drug effects , Adipose Tissue, Brown/drug effects , Adipose Tissue, Brown/growth & development , Animals , Cell Differentiation/drug effects , Fatty Liver/pathology , Interleukin-18/metabolism , Lipid Metabolism/drug effects , Male , Mice, Inbred C57BL , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology , Stem Cells/drug effects , Stem Cells/metabolism , Thermogenesis/drug effects
4.
Pathol Int ; 68(2): 109-116, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29288518

ABSTRACT

Although C5a receptor (C5aR) interacting with its agonist C5a promotes acute inflammation during the initiation phase, the roles of the recycling C5aR during the resolution phase are still unclear. We found that C5aR interacted with its antagonist/agonist ribosomal protein S19 (RP S19) polymer or a RP S19 polymer functional analogue S-tagged C5a/RP S19, which connects an RP S19 C-terminus (IAGQVAAANKKH) to the S-tagged C5a C-terminus, promoted acute inflammation at the resolution phase via an activation of the apoptosis-inducing transcription factor delta lactoferrin (δLf) in neutrophils and the membrane mobilizing factor full-length annexin A3 (ANXA3) in macrophages. To confirm the antagonistic system of the recycling C5aR, S-tagged δLf-coupled BrCN-activated Sepharose 4B beads were incubated with cytoplasmic proteins and identified a neutrophil-specific δANXA3 via pull-down experiments. The S-tagged C5a/RP S19-induced agonistic functions in macrophage-like cells that were differentiated from human promyelocytic leukemia HL-60 cells by phorbol-12-myristate-13-acetate were suppressed by δLf and δANXA3 co-overexpression. δANXA3 seems to participate in the antagonistic system of the neutrophil C5aR involving IAGQVAAANKKH and δLf. Most likely, δANXA3 works as antagonist for the recycling C5aR on neutrophils during the resolution phase of acute inflammation.


Subject(s)
Annexin A3/metabolism , Complement C5a/metabolism , Inflammation/metabolism , Neutrophils/metabolism , Ribosomal Proteins/metabolism , Apoptosis/physiology , Humans , Lactoferrin/metabolism , Macrophages/metabolism , Receptor, Anaphylatoxin C5a/metabolism
5.
Nagoya J Med Sci ; 79(2): 273-277, 2017 02.
Article in English | MEDLINE | ID: mdl-28626263

ABSTRACT

Choline is a new PET tracer, which uptake may occur via a choline-specific transporter protein and be accelerated during the proliferation of tumor cells. We report a 61-year-old woman with a metastatic pancreatic tumor from renal cell carcinoma, measuring 35×40 mm. PET scans demonstrated accumulation of 11C-choline in the metastatic pancreatic tumor, but no accumulation of 18F-FDG. Choline PET/CT may play a useful and complementary imaging modality, especially when FDG-PET/CT does not show expected findings or when the evaluation of tumor viability is needed, in patients with renal cell carcinoma.


Subject(s)
Carcinoma, Renal Cell/drug therapy , Choline/chemistry , Fluorodeoxyglucose F18/analysis , Kidney Neoplasms/drug therapy , Positron Emission Tomography Computed Tomography/methods , Carcinoma, Renal Cell/complications , Female , Humans , Kidney Neoplasms/complications , Middle Aged
6.
Immunogenetics ; 68(1): 55-65, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26552659

ABSTRACT

Interleukin 12 receptor ß chain (IL12RB2) is a crucial regulatory factor involved in cell-mediated immune responses, and genetic variants of the gene encoding IL12RB2 are associated with susceptibility to various immune-related diseases. We previously demonstrated that haplotypes with single nucleotide polymorphisms (SNPs) in the 5' flanking region of IL12RB2, including -1035A>G (rs3762315) and -1023A>G (rs3762316), affect the expression of IL12RB2, thereby altering susceptibility to leprosy and periodontal diseases. In the present study, we identified transcription factors associated with the haplotype-specific transcriptional activity of IL12RB2 in T cells and NK cells. The -1023G polymorphism was found to create a consensus binding site for the transcription factor activating protein (AP)-1, and enzyme-linked immunosorbent assay (ELISA)-based binding assays showed that these SNPs enhanced AP-1 binding to this region. In reporter assays, suppression of JunB expression using siRNA eliminated differences in the -1035G/-1023G and -1035A/-1023A regions containing IL12RB2 promoter activity in Jurkat T cells and NK3.3 cells. These results suggested that the -1035/-1023 polymorphisms created differential binding affinities for JunB that could lead to differential IL12RB2 expression. Moreover, the -1035G and -1035A alleles formed binding sites for GATA-3 and myocyte enhancer factor-2 (MEF-2), respectively. Our data indicated that in addition to JunB, the SNP at -1035/-1023 influenced GATA-3 and MEF-2 binding affinity, potentially altering IL12RB2 transcriptional activity. These findings confirm the effects of rs3762315 and rs3762316 on IL12RB2 transcription. These genetic variants may alter cellular activation of T cells and NK cells and modify cell-mediated immune responses.


Subject(s)
5' Flanking Region , Receptors, Interleukin-12/genetics , Receptors, Interleukin-12/metabolism , GATA3 Transcription Factor/metabolism , Haplotypes , Humans , Jurkat Cells , Killer Cells, Natural/metabolism , MEF2 Transcription Factors/metabolism , Polymorphism, Single Nucleotide , Promoter Regions, Genetic , Transcription Factor AP-1/metabolism , Transcription, Genetic
7.
Surg Today ; 45(4): 506-10, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24522893

ABSTRACT

A 70-year-old male was treated for gastric ulcers. Follow-up upper gastrointestinal endoscopy revealed an irregular, elevated tumor in the second portion of the duodenum. Upon pathological inspection of a biopsy specimen, a diagnosis of adenocarcinoma was made, and the patient was admitted to our hospital. Computed tomography showed an irregular mass in the pancreatic head and dilatation of the main pancreatic duct and bile duct. Pancreatic head carcinoma with infiltration of the duodenum was diagnosed, and pylorus-preserving pancreaticoduodenectomy was performed. A histopathological examination of the resected specimen showed moderately differentiated adenocarcinoma in the minor duodenal papilla and chronic pancreatitis in the pancreatic head. Therefore, primary adenocarcinoma of the minor duodenal papilla with mass-forming chronic pancreatitis was diagnosed. Currently, the patient is alive without recurrence 17 months after the surgery. Primary adenocarcinoma of the minor duodenal papilla is extremely rare. We herein report this case, and also provide a review of the literature.


Subject(s)
Adenocarcinoma/diagnosis , Pancreatic Ducts , Pancreatic Neoplasms/diagnosis , Pancreatitis, Chronic/diagnosis , Adenocarcinoma/complications , Adenocarcinoma/pathology , Aged , Endoscopy, Gastrointestinal , Humans , Magnetic Resonance Imaging , Male , Pancreatic Ducts/diagnostic imaging , Pancreatic Ducts/pathology , Pancreatic Ducts/surgery , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/pathology , Pancreaticoduodenectomy , Pancreatitis, Chronic/complications , Pancreatitis, Chronic/pathology , Tomography, X-Ray Computed , Treatment Outcome
8.
Med Mol Morphol ; 48(3): 169-76, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25547245

ABSTRACT

Tumor necrosis factor-α (TNF-α) directly and indirectly plays a crucial role in osteoclastogenesis. However, the indirect effects of TNF-α on colony-stimulating factor-1 receptor (CSF-1R)-mediated osteoclastogenesis achieved via periodontal ligament (PDL) cells are not fully understood. We herein examined the potency of osteoclast differentiation and maturation induced by fivefold supernatants in the stimulated human PDL cells with a physiologically high concentration (10 ng/mL) of recombinant TNF-α to human peripheral blood monocytes/macrophages in the simultaneous presence of the receptor activator of nuclear factor kappa-B ligand. The number of tartrate-resistant acid phosphatase-positive cells with multiple nuclei, but not those with a single nucleus, was decreased by approximately 50% by neutralization with rabbit IgG against either interleukin-34 (IL-34) or CSF-1. Small and large amounts of IL34 and CSF1 transcripts were measured in the stimulated PDL cells using real-time polymerase chain reaction. The corresponding amounts of proteins to IL34 and CSF1 transcripts were observed in the stimulated PDL cells on immunohistochemical staining or Western blotting. Moreover, 0.13 ng/mL of IL-34 and 5.0 ng/mL of CSF-1 were measured in the supernatants of the stimulated PDL cells using an enzyme-linked immunosorbent assay. IL-34 derived from the stimulated PDL cells with TNF-α appeared to synergistically function with CSF-1 in the CSF-1R-mediated maturation of osteoclastogenesis.


Subject(s)
Cell Differentiation , Interleukins/metabolism , Macrophage Colony-Stimulating Factor/metabolism , Periodontal Ligament/cytology , Tumor Necrosis Factor-alpha/physiology , Enzyme-Linked Immunosorbent Assay , Gene Expression , Humans , Immunohistochemistry , Interleukins/analysis , Interleukins/genetics , Macrophage Colony-Stimulating Factor/analysis , Macrophage Colony-Stimulating Factor/genetics , Periodontal Ligament/drug effects , Periodontal Ligament/metabolism , Real-Time Polymerase Chain Reaction , Stimulation, Chemical
9.
Exp Mol Pathol ; 97(2): 241-6, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25036403

ABSTRACT

The roles of annexin A3 (ANXA3) in macrophages are not fully understood. In contrast to C5a, we have demonstrated that C-terminal ribosomal protein S19 (RP S19)-tagged S-tagged C5a (S-tagged C5a/RP S19) raises an alternative cytoplasmic calcium oscillation by extracellular calcium during macrophage migration into apoptotic cells. We here differentiated human promyelocytic leukemia HL-60 cells bearing with either control sense RNA and shRNA for ANXA3 mRNA or a vector cDNA with or without ANXA3 cDNA into macrophage-like cells by phorbol-12-myristate-13-acetate and found that a fluorescence ratio (340 nm/380 nm) upon the S-tagged C5a/RP S19-induced alternative cytoplasmic calcium oscillation by extracellular calcium was an equilateral association with a dose of ANXA3. Moreover, the ANXA3-dependent modification was partially reflected upon the S-tagged C5a-induced classical cytoplasmic calcium oscillation by both intracellular calcium and extracellular calcium. ANXA3 seems to extend the C5aR-mediated cytoplasmic calcium oscillation by extracellular calcium at least in the HL-60 macrophage-like cells.


Subject(s)
Annexin A3/metabolism , Calcium Signaling , Annexin A3/genetics , Calcium/pharmacology , Cell Differentiation , HL-60 Cells , Humans , Macrophages/drug effects , Macrophages/metabolism , Receptor, Anaphylatoxin C5a/genetics , Receptor, Anaphylatoxin C5a/metabolism , Tetradecanoylphorbol Acetate/pharmacology
10.
Endocr J ; 61(7): 705-15, 2014.
Article in English | MEDLINE | ID: mdl-24759004

ABSTRACT

Vascular endothelial (VE)-cadherin and claudin-5 are major components of the adherens and tight junctions of vascular endothelial cells, respectively, and decreases in their expression are associated with increases in endothelial paracellular permeability. In the uterus, estrogen induces endometrial edema. However, the in vivo effect of estrogen on endothelial paracellular permeability is unknown. Therefore, we studied the expression of VE-cadherin and claudin-5 in vascular endothelial cells in murine uteri stimulated by estrogen or progesterone. Ovariectomized mature mice were injected with estradiol-17ß (1 µg/mouse) or progesterone (1 mg/mouse) at intervals of 24 hours for 6 days. The frozen transverse sections of the uteri of these mice and untreated mice were stained for CD31 (vascular endothelial cell marker) plus VE-cadherin or claudin-5 using a double-immunofluorescence method. Then, the percentages of VE-cadherin- or claudin-5-positive vessels among CD31-positive vessels were examined in the uterine endometria. VE-cadherin and claudin-5 were expressed in most CD31-positive vessels in the endometria of the untreated mice. Progesterone did not affect the expression of both VE-cadherin and claudin-5 and estradiol-17ß also did not affect the VE-cadherin expression, but estradiol-17ß significantly decreased the claudin-5 expression. This decreasing effect of estradiol-17ß was detected from 24 hours later when the water content per a uterus significantly increased. The present study indicates that estrogen, but not progesterone, decreases the expression of claudin-5 in vascular endothelial cells in the murine uterine endometrium from 24 hours later, suggesting that the decrease in the claudin-5 expression contributes to the endometrial edema late after the estrogen stimulation.


Subject(s)
Claudin-5/antagonists & inhibitors , Endothelium, Vascular/drug effects , Estradiol/adverse effects , Estrogen Replacement Therapy/adverse effects , Estrogens/adverse effects , Gene Expression Regulation/drug effects , Uterus/drug effects , Animals , Antigens, CD/genetics , Antigens, CD/metabolism , Biomarkers/metabolism , Cadherins/genetics , Cadherins/metabolism , Claudin-5/genetics , Claudin-5/metabolism , Edema/chemically induced , Edema/metabolism , Edema/pathology , Endometrium/blood supply , Endometrium/drug effects , Endometrium/metabolism , Endometrium/pathology , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Estradiol/administration & dosage , Estrogens/administration & dosage , Female , Injections, Subcutaneous , Mice, Inbred C57BL , Ovariectomy , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Progesterone/administration & dosage , Progesterone/pharmacology , Progestins/administration & dosage , Progestins/pharmacology , Uterine Diseases/chemically induced , Uterine Diseases/metabolism , Uterine Diseases/pathology , Uterus/blood supply , Uterus/metabolism , Uterus/pathology
11.
Cell Tissue Res ; 352(3): 647-57, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23474739

ABSTRACT

VE-cadherin and claudin-5 are major components of adherens and tight junctions of vascular endothelial cells and a decrease in their expression and an increase in the tyrosine-phosphorylation of VE-cadherin are associated with an increase in endothelial paracellular permeability. To clarify the mechanism underlying the development of edema in nasal polyps, we studied these molecules in polyp microvessels. Normal inferior turbinate mucosal tissues and nasal polyps from patients treated with or without glucocorticoid were stained for VE-cadherin or claudin-5 and CD31 by a double-immunofluorescence method and the immunofluorescence intensities were graded 1-3 with increasing intensity. To correct for differences in fluorescence intensity attributable to a different endothelial area being exposed in a section or to the thickness of a section, the relative immunofluorescence intensity was estimated by dividing the grade of VE-cadherin or claudin-5 by that of CD31 in each microvessel. Tyrosine-phosphorylation of VE-cadherin was examined by Western blot analysis. The relative intensities of VE-cadherin and claudin-5 in the CD31-positive microvessels significantly decreased in the following order; inferior turbinate mucosa, treated polyps and untreated polyps. The ratio of tyrosine-phosphorylated VE-cadherin to VE-cadherin was significantly higher in untreated polyps than in the inferior turbinate mucosa and treated polyps, between which no significant difference in the ratio was seen. Thus, in nasal polyps, the barrier function of endothelial adherens and tight junctions is weakened, although glucocorticoid treatment improves this weakened barrier function.


Subject(s)
Antigens, CD/metabolism , Cadherins/metabolism , Claudin-5/metabolism , Endothelium, Vascular/metabolism , Nasal Polyps/metabolism , Adult , Aged , Female , Fluorescence , Humans , Immunohistochemistry , Male , Middle Aged , Nasal Polyps/pathology , Neutrophils/metabolism , Phosphorylation , Phosphotyrosine/metabolism , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Vesicular Transport Proteins/metabolism
12.
Cytokine ; 59(1): 41-8, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22537848

ABSTRACT

OBJECTIVES: Interleukin (IL)-22 acts on non-immune cells to induce anti-microbial responses, protection from tissue damage, and enhance cell regeneration. However, little is known about the involvement of IL-22 in periodontal biology. This study investigated the biological effects of IL-22 on periodontal ligament (PDL) cells as part of studies to assess the involvement of IL-22 in periodontal disease. MATERIALS AND METHODS: Gene expression levels of IL-22 and its receptors in PDL cells and gingival tissue samples were evaluated by real-time PCR. Proliferative responses and mineralized-matrix forming activities of PDL cells were examined in the presence and absence of IL-22. RESULTS: In contrast to the expression of IL-22 receptors detected in PDL tissues and their cell lines, gingival tissues showed modest or no gene expressions of IL-22. The production of several cytokines including IL-11, IL-8 and CCL2 was upregulated by IL-22 treatment of PDL cells in a dose-dependent manner. IL-22 treatment had no effect on the proliferative response in PDL cells. Meanwhile, IL-22 precipitated mineralized nodule formation and induced gene expressions of RUNX2, MSX2 and osteocalcin in PDL cells, suggesting that IL-22 enhances the mineralized matrix-forming activities of PDL cells. CONCLUSION: IL-22 has the potential to promote mineralizing activity in PDL cells and to develop appropriate regenerative therapy.


Subject(s)
Calcification, Physiologic , Interleukins/metabolism , Periodontal Ligament/pathology , Biomarkers/metabolism , Calcification, Physiologic/drug effects , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Clone Cells , Gene Expression Regulation/drug effects , Gingiva/drug effects , Gingiva/metabolism , Humans , Interleukins/pharmacology , Ligands , Osteoblasts/drug effects , Osteoblasts/metabolism , Periodontal Ligament/drug effects , Periodontitis/genetics , Periodontitis/pathology , Receptors, Interleukin/genetics , Receptors, Interleukin/metabolism , Interleukin-22
13.
Surg Today ; 42(10): 1026-31, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22484984

ABSTRACT

We herein report the case of a 48-year-old Japanese female with retroperitoneal epithelioid hemangioendothelioma (EHE), a rare malignant vascular tumor of intermediate grade. She was referred to our hospital because a retroperitoneal tumor was found during a medical checkup, in which strong accumulation of (18)F-fluorodeoxyglucose (FDG) was observed by (18)F-FDG-positron emission tomography (PET). A histological examination of the resected tumor revealed that it consisted of large epithelioid cells with vesicular nuclei, and clear cells with vacuolated cytoplasm and intracytoplasmic lumina. These cells expressed CD31 and vimentin, and the final pathological diagnosis was EHE. Postoperative surveillance with FDG-PET revealed distant metastasis in Virchow's lymph node 7 months after the operation. After dissection of the metastatic lymph node, the patient has been free from recurrence for 13 months. Close follow-up with FDG-PET seemed to be useful for surveillance of the recurrence of this tumor with unpredictable behavior, making an early treatment for the recurrent lesions possible.


Subject(s)
Hemangioendothelioma, Epithelioid/diagnosis , Retroperitoneal Neoplasms/diagnosis , Female , Humans , Middle Aged
14.
Med Mol Morphol ; 45(1): 7-13, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22431178

ABSTRACT

Expression of phenotype markers of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) in HCC and CC components of 20 combined hepatocellular and cholangiocarcinomas (CHCs) of the liver was investigated immunohistochemically. Both HCC and CC components of all CHCs expressed at least one of the CC phenotype markers [cytokeratin (CK)-7, CK-19, and carbohydrate (CA) 19-9]. HCC components in 90% of CHCs and CC components in 95% of CHCs expressed at least one of these CC phenotype markers in more than 40% of cancer cells. HCC components in all CHCs expressed at least one of the HCC phenotype markers [hepatocyte antigen (HA), α-fetoprotein (AFP), and canalicular carcinoembryonic antigen]. HCC components in 90% of CHCs and CC components in 75% of CHCs expressed HA, AFP, or both. HCC components in 75% of CHCs and CC components in 60% of CHCs expressed HA, AFP, or both in more than 10% of cancer cells. The present results show that both HCC and CC components of most of the CHCs expressed both HCC and CC phenotypes, supporting the hypothesis that CHC originates from a hepatic progenitor cell capable of differentiating into hepatocytes and cholangiocytes.


Subject(s)
Bile Duct Neoplasms/pathology , Bile Ducts, Intrahepatic/pathology , Biomarkers, Tumor/metabolism , Carcinoma, Hepatocellular/pathology , Cholangiocarcinoma/pathology , Liver Neoplasms/pathology , Aged , Bile Duct Neoplasms/metabolism , Bile Ducts, Intrahepatic/metabolism , Biomarkers, Tumor/genetics , Carcinoembryonic Antigen/genetics , Carcinoembryonic Antigen/metabolism , Carcinoma, Hepatocellular/metabolism , Cholangiocarcinoma/metabolism , Female , Humans , Keratin-19/metabolism , Liver Neoplasms/metabolism , Male , Middle Aged , Neoplastic Stem Cells/metabolism , Neoplastic Stem Cells/pathology , Phenotype , alpha-Fetoproteins/genetics , alpha-Fetoproteins/metabolism
15.
Med Mol Morphol ; 44(1): 58-62, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21424939

ABSTRACT

A 66-year-old male patient underwent a stomach-preserving pancreatoduodenectomy procedure because of a tumor located around the lower bile duct under the diagnosis of carcinoma of the lower bile duct. The tumor (3.5 × 2.5 cm) was found at the head of the pancreas and had invaded the papillae of Vater at the duodenum. Histology findings indicated both ductal adenocarcinoma and endocrine tumor. The ductal adenocarcinoma component expressed carcinoembryonic antigen, cytokeratin (CK)-19, CK-20, carbohydrate 19-9, and amylase, whereas the endocrine component, which occupied about one-third of the tumor, expressed glucagon, neuron-specific enolase, and chromogranin A. The Ki-67 labeling indices of the two components were 49.7% and 5.3%, respectively. Herein, we present this case of mixed ductal-endocrine carcinoma of the pancreas. Our findings indicate that its aggressive mass may be ascribable to the adenocarcinoma component with a high proliferative potential.


Subject(s)
Adenocarcinoma/pathology , Ampulla of Vater/pathology , Endocrine Gland Neoplasms/pathology , Mixed Tumor, Malignant/pathology , Pancreatic Neoplasms/pathology , Adenocarcinoma/metabolism , Adenocarcinoma/surgery , Aged , Amylases/metabolism , Antigens, Tumor-Associated, Carbohydrate/metabolism , Biomarkers, Tumor/metabolism , Chromogranin A/metabolism , Endocrine Gland Neoplasms/surgery , Fatal Outcome , Female , Glucagon/metabolism , Humans , Keratin-19/metabolism , Keratin-20/metabolism , Ki-67 Antigen/metabolism , Male , Middle Aged , Mixed Tumor, Malignant/metabolism , Mixed Tumor, Malignant/surgery , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/surgery
16.
Cardiovasc Intervent Radiol ; 44(1): 150-155, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33078230

ABSTRACT

PURPOSE: To evaluate the coagulative performance of a 21-gauge (G) internally cooled radiofrequency (RF) electrode using ex vivo and in vivo rat liver. MATERIALS AND METHODS: We developed a prototype of 21-G internally cooled monopolar RF electrode with 5.0 mm active tip length. The ablative zone size created by this electrode was evaluated in ex vivo and in vivo rat liver. Five RF powers (3 W, 5 W, 7 W, 9 W, and 11 W) were applied with and without circulation of chilled water within the electrode. The ablation zone sizes were compared. Histopathological evaluation of the ablation zone was also performed at 24 h and at 7 days after RF ablation. RESULTS: From ex vivo experiments, the ablation volume was found to increase significantly when RF energy was applied with the chilled water circulation. Results of in vivo experiments demonstrate that the ablation volume reached its maximum value when RF power of 7 W was applied (532.3 ± 110.3 mm3). Histopathological examination showed delineated coagulation necrosis at 24 h after RF ablation, which clarified the ablation zone border. Fibrotic change was also observed at 7 days after RF ablation. CONCLUSION: RF ablation using a 21-gauge electrode produced coagulation necrosis in the rat liver. The ablation volume became maximum when RF power of 7 W was applied with chilled water circulation.


Subject(s)
Catheter Ablation/instrumentation , Electrodes , Liver/surgery , Animals , Equipment Design , Male , Models, Animal , Rats , Rats, Sprague-Dawley
17.
Lab Invest ; 90(12): 1747-56, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20680009

ABSTRACT

Fibroblasts act as important immune regulatory cells via their ability to cross-talk with T cells accumulating in lesions. Our previous study showed that fibroblasts produce several cytokines and chemokines by crosslinking HLA class II (HLA-II) molecules with monoclonal antibodies or by making T-cell receptor-peptide-HLA complexes. It is thus conceivable that the interaction of T cells and fibroblasts via HLA-II affects fibroblast responses to stimuli. This study used human gingival fibroblasts (HGF) to investigate possible effects of these fibroblast-derived soluble factors on the differentiation of naïve T cells and on the subsequent fibroblast responses. After mixed lymphocyte reaction culture between naïve T cells and allogeneic dendritic cells in the presence of culture supernatant from HGF stimulated via HLA-DQ molecules (DQ-sup), but not via DR, T cells exhibited a Th2-shifted phenotype, thereby producing quantitatively more IL-13 and IL-5 compared with interferon-γ. Astonishingly, analyses to identify possible factors affecting the Th2 polarization secreted from HLA-II-stimulated HGF, prostaglandin E2, was detected only in DQ-sup. The Th2 polarization of naïve T cells was blocked in the presence of supernatants from indomethacin-treated HGF with HLA-DQ stimulation. In addition, we found that the culture supernatants of Th cells activated following mixed lymphocyte reaction culture in the presence of DQ-sup had the potential to induce gene expression of type I and III collagens in HGF. These results suggested that fibroblasts stimulated via HLA-DQ molecules promote Th2 polarization in Th-cell responses and showed the counter activation of collagen synthesis, implicating orchestrated responses among these cells in the fibrosis of chronic inflammatory lesions.


Subject(s)
Cytokines/biosynthesis , Fibroblasts/immunology , Histocompatibility Antigens Class II/immunology , Prostaglandins E/metabolism , T-Lymphocytes, Helper-Inducer/immunology , Adult , Cell Differentiation/immunology , Cells, Cultured , Cytokines/immunology , Cytokines/metabolism , Dendritic Cells/immunology , Fibroblasts/drug effects , Gingiva/immunology , HLA-DQ Antigens/genetics , HLA-DQ Antigens/immunology , HLA-DQ Antigens/metabolism , Histocompatibility Antigens Class II/genetics , Humans , In Vitro Techniques , Interferon-gamma/immunology , Interferon-gamma/metabolism , Interleukin-13/immunology , Interleukin-13/metabolism , Interleukin-5/immunology , Interleukin-5/metabolism , Lymphocyte Activation/drug effects , Lymphocyte Activation/immunology , Lymphocyte Culture Test, Mixed , Male , Prostaglandins E/immunology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
18.
Med Mol Morphol ; 43(1): 53-9, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20340007

ABSTRACT

A malignant mesothelioma (MM) is an aggressive neoplasm, although some patients have shown long-term survival, and factors related to survival remain uncertain. We present three cases of MM of the peritoneum including autopsy results, in which factors related to long-term survival were investigated. Case 1 was a 69-year-old man who died 6 years after the initial diagnosis. In case 2, a 67-year-old woman came to us with abdominal distention and, despite chemotherapy, died 9 months after the initial diagnosis. The patient in case 3 was a 68-year-old man who also had abdominal distention and died 9 months after the initial diagnosis. We studied the clinicopathological appearance and performed immunohistochemical staining including Ki-67 labeling index (Ki-67 LI) in primary and metastatic sites of these cases. The histological findings of case 1 indicated epithelioid type; case 2 and 3 were of biphasic type. Immunohistochemical results were consistent with MM. The Ki-67 LI value for both primary and metastatic sites of case 1 was significantly lower than those in cases 2 and 3. We consider Ki-67 LI to be a useful prognostic indicator for MM of the peritoneum.


Subject(s)
Mesothelioma/diagnosis , Peritoneal Neoplasms/diagnosis , Aged , Diagnosis, Differential , Disease Progression , Fatal Outcome , Female , Humans , Immunohistochemistry , Ki-67 Antigen/metabolism , Male , Mesothelioma/pathology , Neoplasm Metastasis , Peritoneal Neoplasms/pathology , Survivors
19.
Tumour Biol ; 30(4): 176-84, 2009.
Article in English | MEDLINE | ID: mdl-19738413

ABSTRACT

The effect of immunotherapy with interleukin-18 (IL-18) in combination with preoperative chemotherapy on the postoperative progression of pulmonary metastasis was examined using a spontaneous pulmonary metastasis model of mouse osteosarcoma. Mice were inoculated subcutaneously with highly metastatic murine osteosarcoma cells (LM8) and then underwent chemotherapy with ifosfamide (30 or 60 mg/kg body weight, days 14-16), immunotherapy with IL-18 (2 microg/mouse, days 18-24) or combined immunotherapy and chemotherapy. Tumors developed in mice were excised 21 days after cell inoculation when microscopic but not macroscopic pulmonary metastasis was observed in mice. Three weeks after the excision of the tumors, macroscopic pulmonary metastasis was observed on the surface of the lung. Administration of ifosfamide or IL-18 alone decreased the number of macroscopic pulmonary metastases, and combined administration of ifosfamide and IL-18 resulted in much greater inhibition of pulmonary metastasis. These results suggest that immunotherapy in combination with preoperative chemotherapy is highly effective in suppressing postoperative progression of pulmonary metastasis.


Subject(s)
Bone Neoplasms/immunology , Ifosfamide/therapeutic use , Immunotherapy/methods , Interleukin-18/therapeutic use , Osteosarcoma/immunology , Osteosarcoma/surgery , Animals , Bone Neoplasms/surgery , Cell Line, Tumor , Disease Progression , Female , Mice , Mice, Inbred C3H , Recombinant Proteins/therapeutic use
20.
Jpn J Infect Dis ; 62(5): 381-3, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19762989

ABSTRACT

Pyogenic liver abscess (PLA) formation is thought to originate from the transmission of infection via three major routes including the biliary tract, portal vein and hepatic artery. However, about 50% of PLA cases are considered to be cryptogenic. Here we report an unusual autopsy case of PLA associated with periodontopathic bacterial infection. A 59-year-old female suddenly developed cardiopulmonary arrest and died. Despite macroscopic and microscopic examinations, the infectious routes and source of infection were unidentified, and the case appeared to be cryptogenic. Since this patient had suffered severe periodontitis for a long period of time, we investigated the involvement of periodontal infection in PLA formation by performing immunohistochemical analyses. We identified several periodontopathic bacterial species in the PLA of this patient, including Fusobacterium nucleatum, Treponema denticola, Prevotella intermedia and Porphyromonas gingivalis. Thus, we demonstrate here that periodontal infection is a potential source of infection in the formation of PLA.


Subject(s)
Fusobacterium nucleatum/isolation & purification , Liver Abscess, Pyogenic/microbiology , Periodontal Diseases/complications , Porphyromonas gingivalis/isolation & purification , Prevotella intermedia/isolation & purification , Treponema denticola/isolation & purification , Autopsy , Fatal Outcome , Female , Humans , Kidney/pathology , Liver/pathology , Middle Aged , Myocardium/pathology
SELECTION OF CITATIONS
SEARCH DETAIL